arrow
P

Pedro De Marchi

a.c.camargo cancer center
H指数:15
被引数:2,431

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Malignant salivary gland tumors in Brazil: epidemiology, treatment patterns, and survival outcomes in public Brazilian population

巴西恶性唾液腺肿瘤:流行病学、治疗模式及巴西公共人群中生存结局

2026-04-300
PRE
Hypofractionated Versus Normofractionated Accelerated Radiation Therapy With or Without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO): A Randomized, Open-Label, Phase 3, Noninferiority Trial

局部晚期头颈鳞状细胞癌的加速低分割放疗与常规分割放疗联合或不联合顺铂的比较(HYPNO研究):一项随机、开放标签、III期非劣效性试验

2026-02-190
OAAI
Feasibility of a ctDNA multigenic panel for non-small-cell lung cancer early detection and disease surveillance

循环肿瘤DNA多基因panel在非小细胞肺癌早期检测和疾病监测中的可行性

2025-10-100
OAAI
Real-World Study on Implementation of Genomic Tests for Advanced Lung Adenocarcinoma in Brazil
2024-11-011
OA
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer

HMGB1表达水平与非小细胞肺癌免疫治疗反应相关

2024-05-010
OAAI
Latin American Consensus on the Treatment of Head and Neck Cancer
2024-04-011
PRE
Validation of a 5-gene signature for predicting outcomes in early-stage NSCLC patients
2023-10-271
PRE
Reproducibility of a 12-gene set for predicting outcome and benefit from ACT in earlystage NSCLC patients
2023-10-271
PRE
EGFR Mutation Detection in Brazilian Patients With Non-Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing
2023-09-015
OAAI
Disruptive and truncating TP53 mutations are associated with African-ancestry and worse prognosis in Brazilian patients with lung adenocarcinoma
2023-04-088
PRE
First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update (vol 6, 100273, 2021)
2021-12-013
OAAI
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update

一线nivolumab联合ipilimumab两周期化疗与单纯化疗 (四个周期) 治疗晚期非小细胞肺癌: CheckMate 9LA 2年更新

2021-10-01145
OAAI